Dr. Hoffman is a cell biologist with degrees from Wellesley College and Johns Hopkins University who held R&D executive roles at Vertex Pharmaceuticals, Amgen, and Eli Lilly before founding Origami Therapeutics to develop therapeutics for neurodegenerative diseases.
Intro paths
YC
Beth went through Y Combinator (Winter 2022) — any YC alum in your network can reach them through the YC community.
→
In turn, Beth can intro founders to Origami Therapeutics, Inc.'s investors below.
Origami Therapeutics, Inc.'s investors · 1
Co-founders
Leslie Schulze· Co-Founder and CFO